Journal of Alzheimers Disease & Parkinsonism
黑料网
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 4334
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Reprogramming and programming of human hindbrain cells
3rd International Conference on Parkinsons disease and Movement Disorders
Jianfeng Lu
Tongji University, China
ScientificTracks Abstracts: J Alzheimers Dis Parkinsonism
DOI:
Abstract
Human induced pluripotent stem cells (iPSCs) are derived from somatic cells, such as skin fibroblasts, which keep the whole set of disease genome and could mimic the genetic environment. Without high efficiency of motor neuron differentiation from human iPSCs, it is hard to model motor neuron diseases in a dish using human iPSCs. By the development of a method for efficient conversion human iPSCs into motor neurons, we have successfully modeled motor neuron diseases, such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) in vitro. This will help us understand motor neuron diseases deeply and help the development of effective treatment for the diseases.Biography
Jianfeng Lu is a professor working in Tongji University, Shanghai, China. He has been working in the field of pluripotent stem cells and neuroscience for more than 12 years. By modulating signaling pathways, he and his colleagues are now able to efficiently convert human pluripotent stem cells into different subtypes of neural cells, which offer very useful tools for modeling diseases, for screening drugs and for cell therapy.
